Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lehmann

Showing results (421-430 of 446) with videos related to

Pageof 45
Sort By:
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2014
Essential role of sympathetic endothelin A receptors for adverse cardiac remodelingLorenz H Lehmann, Julia S Rostosky, Sebastian J Buss, et al.
Archives of Cardiovascular Diseases|May 20, 2022
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 29, 2015
[Memorandum on sustainable reinforcement of prevention and health promotion: challenges at the federal, state and local level]U Walter, G Nöcker, S Pawils, et al.
Circulation|January 11, 2000
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypesL Zhang, K W Timothy, G M Vincent, et al.
EMBO Molecular Medicine|September 7, 2014
CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injuryMartin Weinreuter, Michael M Kreusser, Jan Beckendorf, et al.
European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Molecular Metabolism|February 25, 2016
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexiaMichaela Schäfer, Christian U Oeing, Maria Rohm, et al.
The Lancet. Infectious Diseases|December 3, 2014
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trialJoost H C M Kreijtz, Marco Goeijenbier, Fleur M Moesker, et al.
Nature Communications|December 1, 2025
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesisWentao Gui, Petr Paral, Bhavuk Dhamija, et al.
Pageof 45

Showing results (421-430 of 446) with videos related to

Sort By:
Pageof 45
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2014
Essential role of sympathetic endothelin A receptors for adverse cardiac remodelingLorenz H Lehmann, Julia S Rostosky, Sebastian J Buss, et al.
Archives of Cardiovascular Diseases|May 20, 2022
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|May 29, 2015
[Memorandum on sustainable reinforcement of prevention and health promotion: challenges at the federal, state and local level]U Walter, G Nöcker, S Pawils, et al.
Circulation|January 11, 2000
Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypesL Zhang, K W Timothy, G M Vincent, et al.
EMBO Molecular Medicine|September 7, 2014
CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injuryMartin Weinreuter, Michael M Kreusser, Jan Beckendorf, et al.
European Journal of Heart Failure|August 26, 2025
Randomized investigation of heart failure therapy in patients with advanced cancer at risk of cardiac wasting: Rationale and design of the EMPATICC trialMarkus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Molecular Metabolism|February 25, 2016
Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexiaMichaela Schäfer, Christian U Oeing, Maria Rohm, et al.
The Lancet. Infectious Diseases|December 3, 2014
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trialJoost H C M Kreijtz, Marco Goeijenbier, Fleur M Moesker, et al.
Nature Communications|December 1, 2025
MCL1 modulates mTORC1 signaling to promote bioenergetics and tumorigenesisWentao Gui, Petr Paral, Bhavuk Dhamija, et al.
Pageof 45